Reed Malleck

Invicro LLC provides imaging service solutions and analysis software for drug discovery and development. Its solutions include clinical and non-clinical imaging, analytics, data management, histology and tissue imaging and radio and medicinal chemistry. The company was founded by Jack W. Hoppin, Janna Murgia and Christian Lackas in 2008 and is headquartered in Boston, MA.

Emit Imaging, INC. specializes in high-resolution molecular imaging for researchers studying biodistribution, developing genetic models, and using molecular probes. The company is based in Baltimore, MD. The company's platform, Xerra, provides an all-inclusive solution for quantitative 3D fluorescence imaging. Emit Imaging's cryo-fluorescence tomography (CFT) technique allows for the high-resolution visualization of cell clusters, isolated organs, and whole animals. Emit Imaging was founded in 2018, and the CEO is Matt Silva.

World Molecular Imaging Society is an organization that focuses on promoting translational research through multimodality molecular imaging. The private company is based in Los Angeles, CA. The society hosts an annual meeting called the World Molecular Imaging Congress (WMIC), which provides a platform for scientists and clinicians from diverse backgrounds to interact and present cutting-edge advances in molecular imaging. The congress also features industry exhibits showcasing the latest advances in preclinical and clinical imaging approaches and equipment.

The Flare Foundation, Inc. operates as a non-profit organization. The non-profit company is based in Wayland, MA.

The Society of Nuclear Medicine & Molecular Imaging is a non-profit organization that promotes the science, technology, and practical application of nuclear medicine and molecular imaging. The private company is based in Reston, VA.

REALM IDx, Inc. operates health intelligence and visualization platform. The firm provides pharma and clinical services. The company was founded in 2018 and is headquartered in Aliso Viejo, CA.

Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin.

Image Analysis Ltd. operates as an imaging clinical research organization. It supports optimal design and data management of clinical trials. The company was founded by Olga Kubassova in 2007 and is headquartered in London, the United Kingdom.